Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
about
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisAzathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisAzathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisRole of regulatory agencies in translating pharmacogenetics to the clinicsUse of thiopurines in inflammatory bowel diseaseUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Optimizing the use of thiopurines in inflammatory bowel diseaseDrug methylation in cancer therapy: lessons from the TPMT polymorphismPharmacogenetics in inflammatory bowel diseaseGene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityFour human thiopurine s-methyltransferase alleles severely affect protein structure and dynamicsUsing aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.Genes implicated in thiopurine-induced toxicity: Comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort.Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprineTiming of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients.Use of thiopurines in inflammatory bowel disease: Safety issues.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseSafety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis.Is the disease course predictable in inflammatory bowel diseases?Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.Monitoring thiopurine metabolites in korean pediatric patients with inflammatory bowel diseaseAJG series: molecular biology for clinicians.Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.Normal response to vaccines in inflammatory bowel disease patients treated with thiopurinesRecent advances in inflammatory bowel disease.Current status of thiopurine analogues in the treatment in Crohn's disease.Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopeniaThiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patientsAzathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people.Review article: acute severe ulcerative colitis - evidence-based consensus statements.New developments in the treatment of inflammatory bowel disease.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Recent advances in the pharmacogenomics of thiopurine methyltransferase.Review article: monitoring for drug side-effects in inflammatory bowel disease.The genetic jigsaw of inflammatory bowel disease
P2860
Q24185761-269F40AA-95D7-48C9-80D7-328BBC4EE35BQ24200757-153DDA08-1C18-48F6-A3DF-2479B997DD2FQ24243219-B341ADD0-97E1-477F-B005-41BEFE5A7CCCQ24652693-57C45C88-7FC3-412C-AE75-555572D9B38FQ26824662-370585CB-2B36-45C3-8AEC-F9955BE0E149Q26996946-F2FF252B-BEE7-4B9E-9264-3E1CF820BFF0Q28082687-04556EE4-B115-4B3A-AFB5-F023BAF50F0EQ28212325-B52398C4-7EBF-4EEE-B40A-2677B0B90CE5Q28246002-679F7DD1-6DB8-4969-AE9D-BF03B2832C22Q28486322-63DE450D-AFA0-4C75-8EA5-1CB9984D55D1Q30244222-0252B8E0-E9EF-46C4-8B35-2A025A444CFBQ30251388-030758E1-7D09-446E-8E3A-150D8201BE29Q30369449-41D49B91-C07B-4901-BD9A-5903F404DBFFQ30687155-2416AC20-A720-4B7A-8194-AF8ACE7A2939Q31134780-0A2217AB-2BDE-4A74-92B7-9B3BDB3AC4C1Q33380531-2BB3CA35-A3CE-44D3-8363-FDAF438AB219Q33385516-4D07D39F-882B-4D54-9CB8-632EB6BE94BBQ33436894-B86F17CD-1003-480B-BED8-458085564533Q33621267-0FB155FD-A5D0-4E5F-880D-B9CA77933625Q33654733-300CBFE6-B7EA-444D-BE3F-E1F7DA34FEACQ33674158-1135F586-D3EC-4C6B-8F0C-ECD70C658007Q33890504-2D2ECC86-E0FF-4678-B65E-4A70DDAC3A99Q33894191-049DDEC7-0583-4167-96B4-74A06255D9EEQ33905391-0C7FF764-6EEE-4A3F-8711-A0614402A0FEQ33941619-2931419F-23E1-4627-89A5-68154B81D0A8Q33984210-992FB7CE-9E54-441E-B0CD-30F18E1B720CQ34112953-47DFADC6-7371-43E7-ABAA-4B973E499CD2Q34173362-4DB92EC2-16F6-4409-A40D-334D632621D5Q34188405-A7B25FF1-5CBD-4C5B-8309-5BB0F495AE36Q34235370-7AFB5DD0-21ED-46A9-9FFB-D3B31B08D3FFQ34421471-80A04BF5-CBE8-4F24-A0FB-94CCB673373EQ34433052-A360B6DD-EF0C-49B0-83B3-EDDAC3E85DACQ34516280-C11E8A62-206F-4A25-9642-6829F9A16811Q34522550-3C9E5109-1865-4BB0-BCF8-6977D7555D3FQ34528270-B3D44998-8F9B-4208-9955-D47B038F428FQ34544666-86EB1058-7FC7-4A98-853D-60A895A15230Q34564902-24081D14-9166-49CB-BA87-8BFC98BAF7B3Q34574036-B2D54CDD-A60B-4EA3-A907-F42F62F24798Q34585315-375F3E8C-7BE7-437C-8A60-9A88DC72FFCBQ34600985-9508F3D1-C253-44A0-AF35-A258E6600774
P2860
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@ast
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@en
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@nl
type
label
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@ast
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@en
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@nl
prefLabel
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@ast
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@en
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@nl
P2093
P1433
P1476
Genotypic analysis of thiopuri ...... n during azathioprine therapy.
@en
P2093
Colombel JF
Debuysere H
Modigliani R
P304
P356
10.1016/S0016-5085(00)70354-4
P407
P577
2000-06-01T00:00:00Z